HF-REVERT Phase 2 Trial: CDR132L for LV Systolic Dysfunction After MI
For many patients, surviving a myocardial infarction—a heart attack—is only the first hurdle. The real challenge often begins in the weeks that follow, as the heart … Read more
For many patients, surviving a myocardial infarction—a heart attack—is only the first hurdle. The real challenge often begins in the weeks that follow, as the heart … Read more
In the crowded waiting rooms of rural health clinics across Sub-Saharan Africa and Southeast Asia, the “clinical eye” has long been the primary tool for survival. … Read more
For years, the conversation around artificial intelligence governance has been dominated by two extremes: the optimistic marketing of Silicon Valley giants and the alarmist warnings of … Read more
For millions of people, a routine primary care visit often culminates in a high-stakes calculation. A physician plugs age, blood pressure, and cholesterol levels into a … Read more
For patients living with hypereosinophilic syndrome (HES), the body becomes a battlefield. This proves a rare and often unpredictable condition where the bone marrow overproduces eosinophils—white … Read more
For decades, the annual flu shot has been a cornerstone of winter public health, yet it remains a game of predictive guesswork. Each year, scientists must … Read more
For many individuals of African ancestry, a specific genetic blueprint can signal a heightened risk of kidney failure. The APOL1 gene, when carrying high-risk variants, has … Read more
For individuals living with advanced retinitis pigmentosa, the world often shrinks into a narrow tunnel of vision before fading into near-total darkness. This genetic degeneration destroys … Read more
A new partnership between ProImmune, Ltd. And the University of Texas Medical Branch (UTMB) aims to accelerate the study of the world’s most dangerous viruses. By … Read more
For patients facing metastatic pancreatic ductal adenocarcinoma (mPDAC), the clinical landscape has long been defined by limited options and sobering prognoses. Although, new data from a … Read more
In the quiet corridors of a hospital, the most dangerous moments are often the ones that happen silently. A patient’s blood pressure dips slightly, their respiratory … Read more
A 63-year-old man in Norway has achieved long-term remisión del VIH tras un trasplante de células madre, marking a significant medical milestone as the first known … Read more